Search research articles
Contact Us
Filters
Showing results (221-230 of 229) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 229 results.
International Journal of Surgery (London, England)
|
November 14, 2021
P-POSSUM as mortality predictor in COVID-19-infected patients submitted to emergency digestive surgery. A retrospective cohort study
Zoilo Madrazo, Javier Osorio, Sebastián Videla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
International Journal of Surgery (London, England)
|
September 11, 2022
Use of failure-to-rescue after emergency surgery as a dynamic indicator of hospital resilience during the COVID-19 pandemic. A multicenter retrospective propensity score-matched cohort study
Javier Osorio, Zoilo Madrazo, Sebastian Videla, et al.
Theranostics
|
June 29, 2026
NOD1 is a key mediator of atrial myopathy in heart failure
Marta Gil-Fernández, Almudena Val-Blasco, Andrea Bueno-Sen, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 17, 2023
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties
Lia-Raluca Olari, Richard Bauer, Marta Gil Miró, et al.
The New England Journal of Medicine
|
June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
Pathogenic variants in the cohesin loader subunit MAU2 lead to a new Cornelia de Lange Syndrome subtype
Ilaria Parenti, Alina Hesters, Marta Gil-Salvador, et al.
Nature Communications
|
March 30, 2026
Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype
Ilaria Parenti, Alina Hesters, Marta Gil-Salvador, et al.
JAMA Oncology
|
June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
Lucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 229) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 229 results.
International Journal of Surgery (London, England)
|
November 14, 2021
P-POSSUM as mortality predictor in COVID-19-infected patients submitted to emergency digestive surgery. A retrospective cohort study
Zoilo Madrazo, Javier Osorio, Sebastián Videla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2023
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Shannon N Westin, Kathleen Moore, Hye Sook Chon, et al.
International Journal of Surgery (London, England)
|
September 11, 2022
Use of failure-to-rescue after emergency surgery as a dynamic indicator of hospital resilience during the COVID-19 pandemic. A multicenter retrospective propensity score-matched cohort study
Javier Osorio, Zoilo Madrazo, Sebastian Videla, et al.
Theranostics
|
June 29, 2026
NOD1 is a key mediator of atrial myopathy in heart failure
Marta Gil-Fernández, Almudena Val-Blasco, Andrea Bueno-Sen, et al.
Cellular and Molecular Life Sciences : CMLS
|
May 17, 2023
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties
Lia-Raluca Olari, Richard Bauer, Marta Gil Miró, et al.
The New England Journal of Medicine
|
June 5, 2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
Michael R Migden, Danny Rischin, Chrysalyne D Schmults, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
Pathogenic variants in the cohesin loader subunit MAU2 lead to a new Cornelia de Lange Syndrome subtype
Ilaria Parenti, Alina Hesters, Marta Gil-Salvador, et al.
Nature Communications
|
March 30, 2026
Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype
Ilaria Parenti, Alina Hesters, Marta Gil-Salvador, et al.
JAMA Oncology
|
June 25, 2026
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
Lucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, et al.
Page
of 23